Congregational Oversight on the “The Need To Make Insulin Affordable for All Americans”
Part 1 The health issue of insulin’s affordability ignited heated debates in Washington, DC, on 10 May through the hearing from pharmaceutical and pharmacy benefit managers’ executives in the U.S. Senate Committee on Health, Education, Labor, and Pensions. During the hearing, senators heard testimonies and questioned representatives of various insulin manufacturers, including Eli Lilly, Novo ... Read More
Pages: 3 Words: 814